Peptic ulcer disease

@article{Lanas2017PepticUD,
  title={Peptic ulcer disease},
  author={{\'A}. Lanas and F. K. Chan},
  journal={The Lancet},
  year={2017},
  volume={390},
  pages={613-624}
}
The rapidly declining prevalence of Helicobacter pylori infection and widespread use of potent anti-secretory drugs means peptic ulcer disease has become substantially less prevalent than it was two decades ago. Management has, however, become more challenging than ever because of the threat of increasing antimicrobial resistance worldwide and widespread use of complex anti-thrombotic therapy in the ageing population. Peptic ulcers not associated with H pylori infection or the use of non… Expand
1 Citations

References

SHOWING 1-10 OF 131 REFERENCES
Pathogenesis and therapy of gastric and duodenal ulcer disease.
  • 70
Peptic Ulcer Bleeding Risk. The Role of Helicobacter Pylori Infection in NSAID/Low-Dose Aspirin Users
  • 47
  • PDF
Gastroprotective therapy does not improve outcomes of patients with Helicobacter pylori-negative idiopathic bleeding ulcers.
  • G. Wong, K. Au, +4 authors F. K. Chan
  • Medicine
  • Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2012
  • 28
Helicobacter pylori-negative nonsteroidal anti-inflammatory drug-negative ulcer.
  • K. McColl
  • Medicine
  • Gastroenterology clinics of North America
  • 2009
  • 28
...
1
2
3
4
5
...